Postpartum Depression Drug Market – Global Industry, Size, Analysis and Forecast 2018 – 2026

Postpartum Depression Drug Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Postpartum Depression Drug Market – Overview
Increasing research activities for treatment of PPD is expected to propel growth of the postpartum depression drug
market during the forecast period. For instance, Sage Therapeutics is undergoing phase 3 clinical study for the
drug —Brexanolone, which might be useful in the treatment of PPD. The study started in May 2018 and is
estimated to be completed in September 2020.
Furthermore, Marinus Pharmaceuticals, is undergoing clinical phase 2 study for the drug Ganaxolone in the
treatment of PPD and other mood associated disorders. The clinical study started in June 2017 and is expected to
be completed in June 2019.
Postpartum depression (PPD), also known as postnatal depression, is a type of mood disorder that results post
pregnancy. Signs of depression include, insomnia, fatigue and sadness, loss of appetite, mood swings, anxiety, and
anger. Hormonal changes such as elevated prolactin levels, depleted oxytocin and thyroid hormone levels can be a
cause of PPD in females.
REPORT DESCRIPTION
Postpartum Depression Drug Market Taxonomy:
By Drug Class
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants
Atypical Antidepressants
Monoamine Oxidase Inhibitors (MAOIs)
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2258
REPORT DESCRIPTION
Postpartum Depression Drug Market – Key Players
Sage Therapeutics
Sun Pharmaceutical Industries
Cipla Limited
Intas Pharmaceuticals
Mylan N.V
Anikem Laboratories
Shionogi & Co
Antidepressant drugs refusals by the U.S. Food and Drug Administration (U.S FDA) are expected to be a major
restraint in growth of the postpartum depression drug market over the forecast period. For instance, in April 2018,
the U.S FDA refused New Drug Application of Alkermes plc.’s drug candidate ALKS 5461 which is to be
administered orally.
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/postpartum-depression-drug-market-2258
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Increasing research activities for treatment of PPD is expected to propel growth of the postpartum depression drug market